Functional expression of Wilson's disease gene in the LEC rats by adenovirus-mediated gene delivery.

通过腺病毒介导的基因传递,LEC 大鼠中威尔逊氏病基因的功能表达。

基本信息

  • 批准号:
    08670134
  • 负责人:
  • 金额:
    $ 1.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1997
  • 项目状态:
    已结题

项目摘要

WND gene (officially designated ATP7B), which encodes a putative copper transporting P-type ATPase, is defective in the patients with Wilson's disease, resulting in the excessive accumulation of copper in the liver. The Long-Evans Cinnamon (LEC) rat, known as a rodent model for Wilson's disease, shows some of clinical features similar to Wilson's disease. Atp7b, the rat gene homologue to WND,is also defective in the rat. To investigate the in vivo function of WND protein as well as its intracellular localization, WND cDNA was introduced to the LEC rats by recombinant adenovirus mediated gene delivery. The recombinant adenoviruses containing WND cDNA,1X10^<10> plaque forming units, were administered to 4-6 week old LEC rats by tail vein injection. Immunofluorescent study and subcellular fractionation study revealed the transgene expression in liver and its localization to the Golgi apparatus. Moreover, since the synthesis of holoceruloplasmin is disturbed in the LEC rat, the plasma level of holoceruloplasmin, oxidase active and copper bound form, was examined to evaluate the function of WND protein with respect to the copper transport. Consequently, the appearance of holoceruloplasmin in plasma was confirmed by Western blot analysis and plasma measurements for the oxidase activity and the copper content. Conclusions : 1) Introduced WND protein may function in the copper transport coupled with the synthesis of ceruloplasmin. 2) The Golgi apparatus is the likely site for WND protein to manifest its function. 3) Adenovirus mediated gene delivery could be a possible treatment for Wilson's disease.
WND基因(正式命名为ATP 7 B)编码一种假定的铜转运P型ATP酶,在Wilson病患者中是缺陷的,导致铜在肝脏中过度积聚。Long-Evans Cinnamon(LEC)大鼠是Wilson病的啮齿动物模型,其临床表现与Wilson病相似。Atp 7 b是WND的大鼠基因同源物,在大鼠中也有缺陷。为了研究WND蛋白在体内的功能及其在细胞内的定位,本研究利用重组腺病毒介导的基因转移技术将WND cDNA导入LEC大鼠体内。将含有WND cDNA的重组腺病毒(1 × 10 ~ 4噬<10>斑形成单位)尾静脉注射给4-6周龄LEC大鼠。免疫荧光和亚细胞分级分析表明,转基因在肝脏中表达,并定位于高尔基体。此外,由于LEC大鼠中全血浆铜蓝蛋白的合成受到干扰,因此检查了全血浆铜蓝蛋白、氧化酶活性和铜结合形式的血浆水平,以评价WND蛋白在铜转运方面的功能。因此,通过Western印迹分析和血浆中氧化酶活性和铜含量的测量证实血浆中全铜蓝蛋白的出现。结论:1)WND蛋白可能参与铜蓝蛋白的合成和铜转运。2)高尔基体可能是WND蛋白发挥功能的部位。3)腺病毒介导的基因传递可能是治疗Wilson病的一种可能方法。

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yasui O et al.: "Isolation of val cells from Long-Evans Cinnamon rats and their transformation into hepatocytes in vivo in the rat liver." Hepatology. 25. 329-334 (1997)
Yasui O 等人:“从 Long-Evans Cinnamon 大鼠中分离 val 细胞,并在大鼠肝脏中将其转化为体内肝细胞。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kuhara M et al.: "Enhancing effect of a congenital disorder in methionine metabolism on the development of spontaneous hepatitis and hepatoma in LEC rats." J.Trace Elem.Exp.Med.10. 61-71 (1997)
Kuhara M 等人:“甲硫氨酸代谢先天性疾病对 LEC 大鼠自发性肝炎和肝癌发展的增强作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yang X-L et al.: "Two forms of Wilson disease proteins produced by slternative splicing are localized in distinct celluar compartment." Biochem.J. 326. 897-902 (1997)
Yang X-L 等人:“通过选择性剪接产生的两种形式的威尔逊病蛋白位于不同的细胞区室中。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kuhara M et al.: "Enhancing effect of a congenital disorder in methionine methionine metabolism on the development of spontaneous hepatoma in LEC rats." J.Trace Elem.Exp.Med.10. 61-71 (1997)
Kuhara M 等人:“蛋氨酸代谢先天性疾病对 LEC 大鼠自发性肝癌发展的增强作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yang X-L et al.: "Two forms of Wilson disease proteins produced by alternative splicing are localized in distinct cellular compartment." Biochem.J.326. 897-902 (1997)
Yang X-L 等人:“通过选择性剪接产生的两种形式的威尔逊病蛋白位于不同的细胞区室中。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TERADA Kunihiko其他文献

TERADA Kunihiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TERADA Kunihiko', 18)}}的其他基金

Establishment of cell transplantation therapy for Wilson's disease using hepatic stem cells.
建立使用肝干细胞治疗威尔逊氏病的细胞移植疗法。
  • 批准号:
    13670781
  • 财政年份:
    2001
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of functional domains of Wilson's disease protein (ATP7B).
威尔逊氏病蛋白 (ATP7B) 功能域的分析。
  • 批准号:
    10670112
  • 财政年份:
    1998
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

ICF: A novel dual-target gene therapy for safe and efficacious treatment of chronic non-infectious uveitis
ICF:一种安全有效治疗慢性非感染性葡萄膜炎的新型双靶点基因疗法
  • 批准号:
    MR/Z50385X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Research Grant
Longitudinal structural and cognitive functional imaging and outcome prediction in focal epilepsy treated with gene therapy and surgical resection.
基因治疗和手术切除治疗局灶性癫痫的纵向结构和认知功能成像及结果预测。
  • 批准号:
    MR/X031039/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Research Grant
Next-generation automation and PAT implementation for QbD and enhanced approaches for cell and gene therapy
QbD 的下一代自动化和 PAT 实施以及细胞和基因治疗的增强方法
  • 批准号:
    10087446
  • 财政年份:
    2024
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Collaborative R&D
Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
  • 批准号:
    MR/Y019458/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Research Grant
GeneT: The Gene Therapy CoE at the Center of Portugal
GeneT:葡萄牙中心的基因治疗 CoE
  • 批准号:
    10090933
  • 财政年份:
    2024
  • 资助金额:
    $ 1.41万
  • 项目类别:
    EU-Funded
Developing a gene therapy product to treat pressure ulcers in lower-limb amputees
开发一种基因治疗产品来治疗下肢截肢者的压力性溃疡
  • 批准号:
    2888189
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Studentship
Activation of long non-coding RNA by a gene therapy CRISPR/Cas9 approach to prevent vein graft failure
通过基因治疗 CRISPR/Cas9 方法激活长非编码 RNA 以预防静脉移植失败
  • 批准号:
    EP/X024563/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Research Grant
SBIR Phase I: Development of an Adjustable Gene Therapy Platform Technology
SBIR 第一阶段:可调节基因治疗平台技术的开发
  • 批准号:
    2240683
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Standard Grant
Exploration novel effects of SHED-TK-derived exosomes on TK/GCV suicide gene therapy
探索SHED-TK衍生的外泌体对TK/GCV自杀基因治疗的新作用
  • 批准号:
    23K15643
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Gene expression profiling of skin ulcers for short-acting in vivo gene therapy
皮肤溃疡的基因表达谱用于短效体内基因治疗
  • 批准号:
    23K19673
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了